Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Contemporary Clinical Trials|August 14, 2016
NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationaleJoshua D Lee, Edward V Nunes, Patricia Novo Mpa, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2021
Effect of Transdermal Estradiol and Insulin-like Growth Factor-1 on Bone Endpoints of Young Women With Anorexia NervosaVibha Singhal, Amita Bose, Meghan Slattery, et al.
Substance Use & Misuse|April 6, 2012
Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma StudyLesia M Ruglass, Gloria M Miele, Denise A Hien, et al.
The International Journal of Eating Disorders|June 28, 2024
Medical Comorbidities, Nutritional Markers, and Cardiovascular Risk Markers in Youth With ARFIDHelen Burton-Murray, Aluma Chovel Sella, Julia E Gydus, et al.
Addiction (Abingdon, England)|July 26, 2011
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trialsDennis M Donovan, George E Bigelow, Gregory S Brigham, et al.
Journal of Substance Abuse Treatment|June 5, 2012
Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials NetworkDennis M Donovan, Dennis C Daley, Gregory S Brigham, et al.
The Journal of Clinical Psychiatry|December 19, 2013
A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokersTheresa M Winhusen, Gregory S Brigham, Frankie Kropp, et al.
Journal of Consulting and Clinical Psychology|July 29, 2009
Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disordersDenise A Hien, Elizabeth A Wells, Huiping Jiang, et al.
Contemporary Clinical Trials|September 3, 2014
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials NetworkErin A McClure, Susan C Sonne, Theresa Winhusen, et al.
Addiction (Abingdon, England)|March 8, 2016
Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) studyWalter Ling, Maureen P Hillhouse, Andrew J Saxon, et al.
Pageof 5